Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug abuse potential evaluation in animals.

R L Balster1

  • 1Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0613.

British Journal of Addiction
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the discriminative stimulus effects of the low-affinity N-methyl-D-aspartate channel blockers AR-R 13950AA and AR-R 16283AA in rats and rhesus monkeys.

Behavioural pharmacology·2002
Same author

The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects.

Behavioural pharmacology·2002
Same author

GHB: a new and novel drug of abuse.

Drug and alcohol dependence·2001
Same author

The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered.

Behavioural pharmacology·2001
Same author

Introduction to special issue on substance abuse and the immune system.

Drug and alcohol dependence·2001
Same author

Combinations of clozapine and phencyclidine: effects on drug discrimination and behavioral inhibition in rats.

Neuropharmacology·2000
Same journal

Assessment of drug involvement: applications to a sample of physicians in training.

British journal of addiction·1992
Same journal

Severity of DSM-III-R alcohol dependence: United States, 1988.

British journal of addiction·1992
Same journal

Why children start smoking cigarettes: predictors of onset.

British journal of addiction·1992
Same journal

Drinking habits and detection of heavy drinking among middle-aged women.

British journal of addiction·1992
Same journal

Drinking amongst medical patients: levels of risk and models of change.

British journal of addiction·1992
Same journal

Young-adult children of alcoholic parents: protective effects of positive family functioning.

British journal of addiction·1992
See all related articles

Animal laboratory studies assess drug abuse potential using established methods. These preclinical evaluations aid in selecting safer compounds and informing drug abuse prevention strategies.

Area of Science:

  • Pharmacology
  • Toxicology
  • Neuroscience

Background:

  • Animal models are crucial for understanding drug abuse liability.
  • Decades of research have yielded methods to evaluate drug abuse potential in animals.
  • These methods inform regulatory decisions and drug development.

Purpose of the Study:

  • To review preclinical methods for assessing drug abuse liability.
  • To highlight the role of animal studies in drug development and regulation.

Main Methods:

  • Pharmacological equivalence to known drugs of abuse.
  • Drug discrimination studies.
  • Tolerance and cross-tolerance assessments.
  • Physical dependence capacity tests.
  • Drug self-administration studies.

Related Experiment Videos

  • Toxicity and performance impairment evaluations.
  • Main Results:

    • Preclinical studies help identify drug candidates with lower abuse potential.
    • Animal testing complements human subject evaluations for marketed drugs.
    • Results guide regulatory decisions for national and international drug control.

    Conclusions:

    • Animal laboratory studies are vital for preclinical drug abuse liability assessment.
    • These studies support informed decision-making in drug development and abuse prevention.
    • Comprehensive preclinical testing contributes to public health and safety.